In Feb. 2026, China's ex-work price of glyphosate remained generally stable. Affected by the Spring Festival holiday, upstream and downstream firms were slowly resuming operations, leaving the market in a "weak balance" of sluggish supply and demand. Yet, following the recent release of overseas policies, the glyphosate market may soon see a new round of positive momentum, with sentiment shifting from wait-and-see to warming expectations.
On the project front, multiple upstream raw material projects for glyphosate kept advancing: Anhui Ruibai's 90,000 t/a formaldehyde and 60,000 t/a paraformaldehyde project (re-submission) had its EIA application would be publicised; Huai'an Huayuan's, phosphorus trichloride and raw material storage safety enhancement retrofitting project had its EIA application would be publicised; Xiangyang Xingfa's 100,000 t/a food-grade phosphate and supporting 50,000 t/a yellow phosphorus project (Phase I) completion environmental protection acceptance would be publicised.
Corporate developments also emerged: Monsanto agreed to pay USD7.25 billion to settle Roundup herbicide-related cancer lawsuits, further easing its legal risk in The U.S.; Nantong Jiangshan plans to issue up to USD172 million (RMB1.2 billion) in convertible bonds, with part of the raised funds/capital earmarked for investing in new herbicides compatible with glyphosate formulations, aiming to tackle the mounting global issue of glyphosate-resistant weeds.
Policy-wise, the 2026 Central No. 1 Document was officially released, shifting pesticides policy from "reduce volume, raise efficacy" to "raise quality, raise efficacy," stressing scientific application and high-quality industrial development. Overseas, The U.S. issued an executive order list phosphorus as and glyphosate "national security priorities," explicitly safeguarding the strategic position of Monsanto, the nation's sole glyphosate producer—a move that triggered an immediate uptick in relevant domestic share prices.
Export trade data show China exported 21,884.14 t of glyphosate in Nov. 2025, with The U.S. cementing its position as China's top glyphosate export destination.
- February glycine price remains stable
- Yellow phosphorus price rises in February on policy boost
- Glyphosate price holds steady in February
- Nantong Jiangshan expects 2025 net profit to surge over 113%
- Nantong Jiangshan to raise USD172 million to accelerate glyphosate resistance management portfolio
- China's No. 1 central document signals quality shift for crop protection industry
- U.S. declares phosphorus and glyphosate as national security priorities
- Glyphosate formulations with export-only registration in 2025 reach 27
- Registration of eight glyphosate products to be approved in Feb. 2026
- China exports 21,884 tonnes of glyphosate products in Nov. 2025
- Hainan Longping obtains two GM biosafety certificates
- Xingfa Group's key chlor-alkali technology renovation project launches
- Anhui Ruibai's 60,000 t/a paraformaldehyde project (re-submitted)
- Huai'an Huayuan initiates safety upgrade for phosphorus trichloride production
- Hebei Yuhang plans 90,000 t/a paraformaldehyde project
- Xiangyang Xingfa adds 25,000 t/a yellow phosphorus capacity
- Qingdao Jin'er gains expanded registration for glyphosate product in transgenic corn fields
- Fuhua Chemical recognized as national Manufacturing Single-Item Champion Enterprise
- Patent achieves 99.98% yield in catalytic oxidation of PMIDA to glyphosate
- Monsanto to pay USD7.25 billion to settle roundup cancer lawsuits
- Ex-works prices of DEA in China, 25 Feb., 2026
- Ex-works prices of PMIDA in China, 25 Feb., 2026
- Ex-works prices of glycine in China, 25 Feb., 2026
- Ex-works prices of IDAN in China, 25 Feb., 2026
- Ex-works prices of phosphorus trichloride in China, 25 Feb., 2026
- Ex-works prices of isopropylamine in China, 25 Feb., 2026
- Ex-works prices of glyphosate TC in China, the first half of Feb., 2026

